- Mutual Funds
- Tata India Pharma & Healthcare Fund - Direct (G)
Tata India Pharma & Healthcare Fund - Direct (G)
Sectoral / Thematic
- NAV 24.67 (-0.64%)
- Fund Size (Cr) ₹666.91
- Expense Ratio 0.93
- Scheme Type Active Fund
-
Value Research
- Minimum investment ₹5000
- Minimum Additional Investment ₹1000
- Minimum SIP Investment ₹150
- Minimum Withdrawal ₹500
-
Exit Load
0.25%
- Return Since Launch 12.12%
Basic Details
Meeta Shetty
Nifty Pharma TRI
OPEN
Lumpsum Returns
SIP Returns
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
-
Investment Type
-
Monthly Investment
₹ -
Expected Returns Rate
% -
Time Period
yrs
Total of your Investment will be
₹ 0
Returns
-
Invested Amount
0
-
Estimated Returns
0
-
Select Scheme
-
Investment Type
-
Monthly Investment
₹ -
Time Period
Total of your Investment will be
₹ 0
Returns
-
Invested Amount
0
-
Estimated Returns
0
Risk Ratios
-
Standard Deviation
0.67% -
Beta
0.35% -
Sharpe Ratio
0.13% -
Treynor’s Ratio
0.25% -
Jension’s Alpha
0.09%
Asset Allocation
There is no Asset Allocation data.
Sector Allocation
There is no Sector Allocation data.
Top 10 stock holding in portfolio
Peer Comparison
- Scheme Name
- Value Research
- Asset Size (Cr)
- 1M
- 3M
- 6M
- 1Y
- 3Y
-
Tata India Pharma & Healthcare Fund - Direct (G)
- 666.91
- 7.77%
- 8.40%
- 26.68%
- 31.19%
- 15.84%
-
HDFC Infrastructure Fund - Direct (G)
- 957.81
- 10.69%
- 12.04%
- 37.81%
- 47.74%
- 39.94%
-
HDFC Infrastructure Fund - Direct (IDCW)
- 957.81
- 10.69%
- 12.04%
- 37.81%
- 47.72%
- 39.93%
-
Aditya Birla SL PSU Equity Fund - Direct (G)
- 1312.62
- 15.95%
- 18.34%
- 40.62%
- 46.66%
- 39.90%
-
Aditya Birla SL PSU Equity Fund - Direct (IDCW)
- 1312.62
- 15.96%
- 18.34%
- 40.58%
- 46.63%
- 39.89%
-
Nippon India Power & Infra Fund - Direct (G)
- 2707.21
- 11.80%
- 13.16%
- 32.32%
- 46.07%
- 37.12%
News
-
Tata Equity P/E Fund Announces Income Distribution cum Capital Withdrawal (IDCW)
Tata Mutual Fund has announced 21 November 2023 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under the IDCW option of Tata Equity P/E Fund. The amount of IDCW on the face value of Rs 10 per unit will be:
Tata Equity P/E Fund - Regular Plan ? IDCW Trigger ? Option A (5%): Rs 1.25
Tata Equity P/E Fund - Direct Plan ? IDCW Trigger ? Option A (5%): Rs 1.35
Powered by Capital Market - Live News
-
Tata MF Announces change in scheme name
Tata Mutual Fund has announced change in scheme name under the following scheme, with effect from 06 November 2023:
Change in the Scheme Name:
Existing Name Revised Name Tata India Tax Savings Fund Tata ELSS Tax Saver Fund Powered by Capital Market - Live News
-
Tata MF Announces Income Distribution cum capital withdrawal (IDCW) under two schemes
Tata Mutual Fund has announced 01 November 2023 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under the monthly IDCW option and under the Periodic IDCW Periodic-Payout/Reinvestment) of following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:
Tata Hybrid Equity Fund ? Regular Plan & Direct Plan: 0.31 each.
Tata Equity Savings Fund ? Regular Plan & Direct Plan: 0.052 each.
Powered by Capital Market - Live News
Fund House Details & Investment Objective
-
Date of Incorporation
04-Dec-2015
-
Total AUM (Cr)
₹666.91
Tata India Pharma & Healthcare Fund - Direct (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, Tata Mutual Fund. Launched in Dec 2015, this fund is managed by Meeta Shetty. With assets under management (AUM) worth ₹666.91 (Cr), as of 08-Dec-2023, Tata India Pharma & Healthcare Fund - Direct (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 12.12% since its launch.
The current NAV of Tata India Pharma & Healthcare Fund - Direct (G) is ₹24.67, as on 08-Dec-2023. The fund’s benchmark index is Nifty Pharma TRI. You can invest in Tata India Pharma & Healthcare Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹150 while the minimum lumpsum investment is ₹5000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.
The fund has generated 15.84% and 22.32% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 95.9% in Equity, 0.44% in Debt and 3.66% in cash and cash equivalents
The top 5 sectors the fund invests in are: 80.92% in Pharmaceuticals & Biotechnology, 13.66% in Healthcare Services, 2.77% in Cash & Others, 1.46% in Retailing and 0.83% in Fertilisers & Agrochemicals.
FAQs on Tata India Pharma & Healthcare Fund - Direct (G)
Tata India Pharma & Healthcare Fund - Direct (G) is a popular fund in the Sectoral / Thematic segment. The fund has generated a return of 12.12% since inception. Looking to invest in Tata India Pharma & Healthcare Fund - Direct (G)? How about earning 1% extra return? All this is possible with m.Stock! Investing in Tata India Pharma & Healthcare Fund - Direct (G) is super easy and convenient with m.Stock. Here’s how you can begin:
- Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage across products for life.
- In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
- In the search bar, enter the fund name, in this case, Tata India Pharma & Healthcare Fund - Direct (G)
- On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
- If you choose to invest a Lumpsum: Enter amount, select payment mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
- If you choose the SIP route, then enter SIP amount, SIP date, and set up ‘Autopay’ facility.
So, why wait? Invest in Tata India Pharma & Healthcare Fund - Direct (G) today and reap the benefits of this Sectoral / Thematic fund!
In the short term, i.e., 1 year, Tata India Pharma & Healthcare Fund - Direct (G) has generated annualised return of 31.19%. In the long-term, the fund has generated 15.84% and 22.32% in 3 and 5 years respectively. Since its inception, the fund has generated 12.12% returns.
The expense ratio of Tata India Pharma & Healthcare Fund - Direct (G) Direct Growth is 0.93%. Expense ratio is the fees payable by investors of the scheme towards management, research and overall upkeep of the fund. The higher the expense ratio, the lower is the in-hand return for the investor. Expense ratio for direct plans is lower than regular plans, making them ideal for investors.
The Assets Under Management (AUM) of Tata India Pharma & Healthcare Fund - Direct (G) is ₹666.91 (Cr) as of 08 December 2023. AUM shows the fund’s popularity and is often indicative of fund strength.
Redeeming or selling units of Tata India Pharma & Healthcare Fund - Direct (G) is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.
To redeem from Tata India Pharma & Healthcare Fund - Direct (G):
- Login to your m.Stock account
- In portfolio, your mutual fund investments will be visible under ‘MF’
- Select the fund you wish to redeem from (in this case Tata India Pharma & Healthcare Fund - Direct (G)).
- Click on ‘Redeem’ button
- You have 2 options – redeem by units and redeem by value (you can only redeem free units)
- Select units to be redeemed and click on submit.
- Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).
Yes, you can invest both lumpsum and SIP in Tata India Pharma & Healthcare Fund - Direct (G). Minimum lumpsum investment Tata India Pharma & Healthcare Fund - Direct (G) is ₹5000 and minimum SIP amount is ₹150. Lumpsum option is ideal for investors with higher investible corpus and market experience. SIP option is recommended for retail investors who do not have the time or expertise to time the market.
The latest NAV (Net Asset Value) of Tata India Pharma & Healthcare Fund - Direct (G) is ₹24.67 as on 08 December 2023.
The 5 biggest stock holdings of Tata India Pharma & Healthcare Fund - Direct (G) are:
Sun Pharma.Inds. (12.48%), Lupin (10.88%), Dr Reddy's Labs (9.4%), Aurobindo Pharma (7.78%), Cipla (7.29%)
A majority of Tata India Pharma & Healthcare Fund - Direct (G) 's AUM worth ₹666.91 (Cr) is invested in these 3 top sectors:
- Pharmaceuticals & Biotechnology: 80.92%
- Healthcare Services: 13.66%
- Cash & Others: 2.77%
Power your investments with our smart trading platforms
